This report provides a comprehensive analysis of the global Virtual Oncology market, detailing its rapid expansion driven by the increasing adoption of teleoncology and digital diagnostic tools. Covering the period from 2025 to 2032, the study examines market dynamics across software, hardware, and service segments, as well as applications in hospitals and research centers. Through detailed regional breakdowns and competitive profiling of key industry players, the research identifies emerging growth opportunities and strategic trends shaping the future of digital cancer care.

Market Overview

The global Virtual Oncology market size is predicted to grow from US$ 4217 million in 2025 to US$ 9936 million in 2032; it is expected to grow at a CAGR of 13.3% from 2026 to 2032.

Virtual Oncology generally refers to the use of virtual or digital technologies in the field of oncology, which is the branch of medicine that deals with the prevention, diagnosis, and treatment of cancer.

Key Market Trends and Drivers

• Expansion of Teleoncology Services: Teleoncology services, including remote consultations, follow-ups, and monitoring, continue to expand.
• Improved Access to Care: The use of video conferencing, secure messaging, and other telecommunication tools allows oncology professionals to connect with patients regardless of geographic locations, improving access to care.

Report Scope and Methodology

LPI (LP Information)' newest research report, the “Virtual Oncology Industry Forecast” looks at past sales and reviews total world Virtual Oncology sales in 2025, providing a comprehensive analysis by region and market sector of projected Virtual Oncology sales for 2026 through 2032. With Virtual Oncology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virtual Oncology industry.

This Insight Report provides a comprehensive analysis of the global Virtual Oncology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Virtual Oncology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virtual Oncology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virtual Oncology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virtual Oncology. This report presents a comprehensive overview, market shares, and growth opportunities of Virtual Oncology market by product type, application, key players and key regions and countries.

Market Segmentation

By Type

• Software
• Service
• Hardware

By Application

• Hospitals & Diagnostic Imaging Centers
• Academic Institutions & Research Centers
• Pharma & Biotech Companies
• Contract Research Organizations (CROs)
• Others

By Geography

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

The companies profiled below have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, and its market penetration:

• McKesson Corporation
• Cerner Corporation
• Koninklijke Philips N.V.
• Siemens Healthcare Private Limited
• Crisp
• Varian Medical Systems, Inc.
• Elekta AB
• Accuray Incorporated
• C-TAC Health
• Oscar Health
• NXGN Management, LLC
• Epic Systems Corporation
• Optum, Inc
• CureMatch, Inc.
• Oncora Medical

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Virtual Oncology Market Size (2021-2032)

    • 2.1.2 Virtual Oncology Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Virtual Oncology by Country/Region (2021, 2025 & 2032)

  • 2.2 Virtual Oncology Segment by Type

    • 2.2.1 Software

    • 2.2.2 Service

    • 2.2.3 Hardware

    • 2.2.4 Virtual Oncology Market Size by Type

      • 2.2.4.1 Virtual Oncology Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.4.2 Global Virtual Oncology Market Size Market Share by Type (2021-2026)

  • 2.3 Virtual Oncology Segment by Application

    • 2.3.1 Hospitals & Diagnostic Imaging Centers

    • 2.3.2 Academic Institutions & Research Centers

    • 2.3.3 Pharma & Biotech Companies

    • 2.3.4 Contract Research Organizations (CROs)

    • 2.3.5 Others

    • 2.3.6 Virtual Oncology Market Size by Application

      • 2.3.6.1 Virtual Oncology Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.6.2 Global Virtual Oncology Market Size Market Share by Application (2021-2026)

• 3 Virtual Oncology Market Size by Player

  • 3.1 Virtual Oncology Market Size Market Share by Player

    • 3.1.1 Global Virtual Oncology Revenue by Player (2021-2026)

    • 3.1.2 Global Virtual Oncology Revenue Market Share by Player (2021-2026)

  • 3.2 Global Virtual Oncology Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Virtual Oncology by Region

  • 4.1 Virtual Oncology Market Size by Region (2021-2026)

  • 4.2 Global Virtual Oncology Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Virtual Oncology Market Size Growth (2021-2026)

  • 4.4 APAC Virtual Oncology Market Size Growth (2021-2026)

  • 4.5 Europe Virtual Oncology Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Virtual Oncology Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Virtual Oncology Market Size by Country (2021-2026)

  • 5.2 Americas Virtual Oncology Market Size by Type (2021-2026)

  • 5.3 Americas Virtual Oncology Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Virtual Oncology Market Size by Region (2021-2026)

  • 6.2 APAC Virtual Oncology Market Size by Type (2021-2026)

  • 6.3 APAC Virtual Oncology Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Virtual Oncology Market Size by Country (2021-2026)

  • 7.2 Europe Virtual Oncology Market Size by Type (2021-2026)

  • 7.3 Europe Virtual Oncology Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Virtual Oncology by Region (2021-2026)

  • 8.2 Middle East & Africa Virtual Oncology Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Virtual Oncology Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Virtual Oncology Market Forecast

  • 10.1 Global Virtual Oncology Forecast by Region (2027-2032)

    • 10.1.1 Global Virtual Oncology Forecast by Region (2027-2032)

    • 10.1.2 Americas Virtual Oncology Forecast

    • 10.1.3 APAC Virtual Oncology Forecast

    • 10.1.4 Europe Virtual Oncology Forecast

    • 10.1.5 Middle East & Africa Virtual Oncology Forecast

  • 10.2 Americas Virtual Oncology Forecast by Country (2027-2032)

    • 10.2.1 United States Market Virtual Oncology Forecast

    • 10.2.2 Canada Market Virtual Oncology Forecast

    • 10.2.3 Mexico Market Virtual Oncology Forecast

    • 10.2.4 Brazil Market Virtual Oncology Forecast

  • 10.3 APAC Virtual Oncology Forecast by Region (2027-2032)

    • 10.3.1 China Virtual Oncology Market Forecast

    • 10.3.2 Japan Market Virtual Oncology Forecast

    • 10.3.3 Korea Market Virtual Oncology Forecast

    • 10.3.4 Southeast Asia Market Virtual Oncology Forecast

    • 10.3.5 India Market Virtual Oncology Forecast

    • 10.3.6 Australia Market Virtual Oncology Forecast

  • 10.4 Europe Virtual Oncology Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Virtual Oncology Forecast

    • 10.4.2 France Market Virtual Oncology Forecast

    • 10.4.3 UK Market Virtual Oncology Forecast

    • 10.4.4 Italy Market Virtual Oncology Forecast

    • 10.4.5 Russia Market Virtual Oncology Forecast

  • 10.5 Middle East & Africa Virtual Oncology Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Virtual Oncology Forecast

    • 10.5.2 South Africa Market Virtual Oncology Forecast

    • 10.5.3 Israel Market Virtual Oncology Forecast

    • 10.5.4 Turkey Market Virtual Oncology Forecast

  • 10.6 Global Virtual Oncology Forecast by Type (2027-2032)

  • 10.7 Global Virtual Oncology Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Virtual Oncology Forecast

• 11 Key Players Analysis

  • 11.1 McKesson Corporation

    • 11.1.1 McKesson Corporation Company Information

    • 11.1.2 McKesson Corporation Virtual Oncology Product Offered

    • 11.1.3 McKesson Corporation Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 McKesson Corporation Main Business Overview

    • 11.1.5 McKesson Corporation Latest Developments

  • 11.2 Cerner Corporation

    • 11.2.1 Cerner Corporation Company Information

    • 11.2.2 Cerner Corporation Virtual Oncology Product Offered

    • 11.2.3 Cerner Corporation Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Cerner Corporation Main Business Overview

    • 11.2.5 Cerner Corporation Latest Developments

  • 11.3 Koninklijke Philips N.V.

    • 11.3.1 Koninklijke Philips N.V. Company Information

    • 11.3.2 Koninklijke Philips N.V. Virtual Oncology Product Offered

    • 11.3.3 Koninklijke Philips N.V. Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Koninklijke Philips N.V. Main Business Overview

    • 11.3.5 Koninklijke Philips N.V. Latest Developments

  • 11.4 Siemens Healthcare Private Limited

    • 11.4.1 Siemens Healthcare Private Limited Company Information

    • 11.4.2 Siemens Healthcare Private Limited Virtual Oncology Product Offered

    • 11.4.3 Siemens Healthcare Private Limited Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Siemens Healthcare Private Limited Main Business Overview

    • 11.4.5 Siemens Healthcare Private Limited Latest Developments

  • 11.5 Crisp

    • 11.5.1 Crisp Company Information

    • 11.5.2 Crisp Virtual Oncology Product Offered

    • 11.5.3 Crisp Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Crisp Main Business Overview

    • 11.5.5 Crisp Latest Developments

  • 11.6 Varian Medical Systems, Inc.

    • 11.6.1 Varian Medical Systems, Inc. Company Information

    • 11.6.2 Varian Medical Systems, Inc. Virtual Oncology Product Offered

    • 11.6.3 Varian Medical Systems, Inc. Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Varian Medical Systems, Inc. Main Business Overview

    • 11.6.5 Varian Medical Systems, Inc. Latest Developments

  • 11.7 Elekta AB

    • 11.7.1 Elekta AB Company Information

    • 11.7.2 Elekta AB Virtual Oncology Product Offered

    • 11.7.3 Elekta AB Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Elekta AB Main Business Overview

    • 11.7.5 Elekta AB Latest Developments

  • 11.8 Accuray Incorporated

    • 11.8.1 Accuray Incorporated Company Information

    • 11.8.2 Accuray Incorporated Virtual Oncology Product Offered

    • 11.8.3 Accuray Incorporated Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Accuray Incorporated Main Business Overview

    • 11.8.5 Accuray Incorporated Latest Developments

  • 11.9 C-TAC Health

    • 11.9.1 C-TAC Health Company Information

    • 11.9.2 C-TAC Health Virtual Oncology Product Offered

    • 11.9.3 C-TAC Health Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 C-TAC Health Main Business Overview

    • 11.9.5 C-TAC Health Latest Developments

  • 11.10 Oscar Health

    • 11.10.1 Oscar Health Company Information

    • 11.10.2 Oscar Health Virtual Oncology Product Offered

    • 11.10.3 Oscar Health Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Oscar Health Main Business Overview

    • 11.10.5 Oscar Health Latest Developments

  • 11.11 NXGN Management, LLC

    • 11.11.1 NXGN Management, LLC Company Information

    • 11.11.2 NXGN Management, LLC Virtual Oncology Product Offered

    • 11.11.3 NXGN Management, LLC Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 NXGN Management, LLC Main Business Overview

    • 11.11.5 NXGN Management, LLC Latest Developments

  • 11.12 Epic Systems Corporation

    • 11.12.1 Epic Systems Corporation Company Information

    • 11.12.2 Epic Systems Corporation Virtual Oncology Product Offered

    • 11.12.3 Epic Systems Corporation Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Epic Systems Corporation Main Business Overview

    • 11.12.5 Epic Systems Corporation Latest Developments

  • 11.13 Optum, Inc

    • 11.13.1 Optum, Inc Company Information

    • 11.13.2 Optum, Inc Virtual Oncology Product Offered

    • 11.13.3 Optum, Inc Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Optum, Inc Main Business Overview

    • 11.13.5 Optum, Inc Latest Developments

  • 11.14 CureMatch, Inc.

    • 11.14.1 CureMatch, Inc. Company Information

    • 11.14.2 CureMatch, Inc. Virtual Oncology Product Offered

    • 11.14.3 CureMatch, Inc. Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 CureMatch, Inc. Main Business Overview

    • 11.14.5 CureMatch, Inc. Latest Developments

  • 11.15 Oncora Medical

    • 11.15.1 Oncora Medical Company Information

    • 11.15.2 Oncora Medical Virtual Oncology Product Offered

    • 11.15.3 Oncora Medical Virtual Oncology Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Oncora Medical Main Business Overview

    • 11.15.5 Oncora Medical Latest Developments

• 12 Research Findings and Conclusion